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Introduction: Embryonal rhabdomyosarcoma of the female genital tract is rare in the cervix. It has been mainly
discussed in the context of individual case studies. It tends to occur in children and young women. Treatment
ranges from radical surgery to conservative surgery, followed by chemotherapy.
Case presentation: A 16-year-old Moroccan adolescent girl presented to our center with a protruding mass from her
vaginal introitus, as a polyp of 6cm. An examination revealed a polyp within her vagina, thought to be arising from her
cervix and a polypectomy was performed. Microscopic findings are consistent with an embryonal rhabdomyosarcoma
(botryoide type). A computed tomography of her thorax, abdomen and pelvis were performed and residual disease
was found as a mass located at her cervix, which measured approximately 4.5cm in its widest dimensions, without
evidence of metastatic disease. Due to the fact that she is young, after discussions in a multidisciplinary meeting, she
was subsequently treated with four cycles of multi-agent chemotherapy. Two cycles of chemotherapy and radiotherapy
were administered due to the lack of response, but she presented vaginal bleeding with persistence of the same mass
in computed tomography. Hence a total interadnexal hysterectomy was made. A histologic examination found residual
embryonal rhabdomyosarcoma (botryoide type) located in all her cervix and she is currently under chemotherapy.
Conclusions: The presence of a cervical polyp in an adolescent is a gynecologic oddity and must necessarily be
examined histologically because it might be a rhabdomyosarcoma. This is extremely important because diagnosis at an
early stage of the disease is a highly favorable prognostic factor that allows “fertility-sparing surgery” for these young
patients.
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Rhabdomyosarcoma (RMS) is a tumor of skeletal muscle
that is classified by the World Health Organization (2013)
into embryonal RMS (including botryoide, anaplastic),
alveolar RMS (including solid, anaplastic), pleomorphic
RMS and spindle cell/sclerosing RMS [1]. RMS is a highly
malignant tumor arising from embryonal mesenchyma,
and it is the commonest soft tissue sarcoma in childhood
and young adults [2]. It accounts for 4 to 6% of all* Correspondence: jayisofia@yahoo.fr
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unless otherwise stated.malignancies in this age group [2]. Because of the extreme
rarity of cervical RMS, there is a paucity of literature on
the subject consisting mainly of case reports [3,4] in which
the treatment is not codified [5].
We report a case of embryonal RMS that presented as a
cervical polyp protruding from the vaginal introitus in a
young teenager, treated by hysterectomy after chemo-
therapy and radiotherapy. Through this case, we emphasize
the diagnosis, management and prognosis factors.Case presentation
A 16-year-old Moroccan girl presented to our center
with a protruding mass from her vaginal introitus which. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a ‘grape-like’ appearance, smooth, glistening, and focally
hemorrhagic. A computed tomography (CT) scan of her
pelvis was requested but the family refused due to lack
of finance. She was taken to the operating room, at
which time the examination revealed a polyp within her
vagina, thought to be arising from her cervix and a
polypectomy was performed.
On microscopic examination, the polyp was covered by
squamous and endocervical mucosa. The rhabdomyoblastic
nature of the tumor cells was noted by the small-rounded
tumor cells, and an eosinophilic cytoplasm with atypical
nuclei. Immunohistochemical analysis revealed that tumor
cells were immunoreactive to desmin. Nuclear reactivity to
myogenin was strong on less than 50% of nuclei. However,
the tumor cells were not immunoreactive to cytokeratin.
These findings are consistent with an embryonal RMS
(botryoide type; Figure 1a, b). A CT of her thorax, abdo-
men and pelvis were performed, and residual disease was
found as a mass located at her cervix, it measured appro-
ximately 4.5cm in its widest dimensions (Figure 2a, b),
without evidence of metastatic disease.
After discussions in a multidisciplinary meeting (because
she is young) she was subsequently treated with four cycles
of multi-agent chemotherapy: vincristine, Adriamycin®,
cyclophosphamide (VAC). Because of a lack of response,
two cycles of chemotherapy (cisplatin and etoposide) and
radiotherapy were administered, but she presented vaginal
bleeding with persistence of the same mass in CT, hence a
total interadnexal hysterectomy was made. A histologic
examination found residual embryonal RMS located in all
her cervix; she is currently under chemotherapy.
Discussion
When an embryonal RMS affects the genitourinary tract,
the vagina is the most common site [6]. Only 0.5% of
primary RMSs in girls are found on the cervix [4]; it has
been reported in babies as young as 5 months of age [7],Figure 1 Sections of tumor showing. a: Hematoxylin and eosin staining
small-rounded tumor cells under the surface epithelium (arrow).but it is usually seen in the second decade of life as is the
case in our patient, unlike vaginal lesions which usually
present before the age of 4 years [2,4]. The vast majority
of RMS cases occur sporadically with no recognized pre-
disposing factor or risk factors, although a small propor-
tion is associated with genetic conditions. Li–Fraumeni
cancer susceptibility syndrome, evident by a clustering of
soft tissue malignancies (including sarcomas), has been
discovered in a family to be caused by a heterozygous
germline p.53 mutation [3-8]. Dehner et al. also found a
link to the pleuropulmonary blastoma family of tumors
with confirmed DICER1 mutations, and reports that RMS
in children should be viewed and managed in a broader
context to include the possibility of familial pleuro-
pulmonary blastoma tumor predisposition syndrome [3].
Our patient could not seek genetic counseling because of
a lack of resources.
Most patients present with a feeling of a mass in the
introitus. The tumor, as is the case in our patient, may
form soft, grape-like clusters, present as single or multiple
polyps [1,4,9]. Additional symptoms included leukorrhea,
bleeding, and malodorous discharge [4]. However, the
polyp may sometimes take the appearance of a benign
mucous polyp relapsed after excision, which may cause a
delay in diagnosis [5].
The gross examination showed that the tumors are
polypoid with a ‘grape-like’ appearance, smooth, glistening,
and focally hemorrhagic [6,10]. They are microscopically
characterized by rhabdomyoblasts, and by small round to
oval spindled cells [6]. The pathologic differential diagno-
sis includes benign entities such as rhabdomyoma and an
edematous mesodermal cervical polyp (pseudosarcoma
botryoides), and malignant entities such as adenosarcoma
and other “small, round, blue cell” tumors [1,3].
Primaries RMSs of the cervix are so rare that no single
institution has adequate experience to identify superior
therapeutic strategies [8-11], but treatment of embryonal
RMS of genitourinary primary can be extrapolated to×40; polypoid formation. b: Hematoxylin and eosin staining ×200; the
Figure 2 Pelvic scan with injection of product of contrast. (a) Axial and (b) sagittal section showing a tumor mass in the cervical region
(arrows) enhanced by the product of contrast.
Table 1 Intergroup Rhabdomyosarcoma Study Group
clinical classification system for rhabdomyosarcoma [4]
Clinical group, extent of disease, resectability, and margin status
I A: localized tumor confined to site of origin completely resected
B: localized tumor infiltrating beyond site of origin completely resected
II A: localized tumor gross total resection but with microscopic
residual disease
B: locally extensive tumor ( spread to regional lymph nodes)
completely resected
III A: localized or locally extensive tumor gross residual disease
after biopsy only
B: localized or locally extensive tumor gross residual disease
after major resection (≥50% debulking)
IV Any size primary tumor with or without regional lymph node
involvement with distant metastases irrespective of
surgical approach to primary tumor
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cervix is traditionally radical, it is a surgery which compro-
mises fertility [11]. However, because the peak incidence
of this tumor occurs in young females, patients often
desire to retain their fertility potential. The recent litera-
ture suggests that sarcoma botryoides of the cervix behave
less aggressively than sarcoma botryoides of the vagina
and uterus; that is why the management of RMS of the
female genital tract has evolved toward conservation of
the genitourinary organs [7,5]. Four studies by the Inter-
group Rhabdomyosarcoma Study Group (IRSG) [6] reveal
that they moved from aggressive surgery (hysterectomy)
and radiation to an intensive primary chemotherapy
(VAC), without appreciable change in survival (5 years’
survival 82% for surgery/radiation versus 84% for chemo-
therapy) [7], while maintaining fertility and reduced long-
term morbidity from radiation therapy [4,8]. In fact, in
addition to VAC chemotherapy, a cone biopsy or a poly-
pectomy are performed to establish a definitive diagnosis,
to reduce tumor burden and to minimize the symptom-
atology of vaginal discomfort, bleeding and vaginal dis-
charge. Radiation is largely reserved for salvage therapy in
the recurrent setting for patients of advanced age who
could not tolerate intensive chemotherapy [4]. According
to the IRSG, fertility-sparing surgery followed by chemo-
therapy is the appropriate treatment for patients with local
disease [11,12] (Table 1). However, there are case reports
of unfavorable outcomes despite an adequate surgical
excision and chemotherapy, interjecting a note of caution
and emphasizing the need for close clinical follow-up [7].
Fertility-sparing surgery should not be considered with the
presence of extensive uterine involvement and/or metasta-
sis. The presence of a deep myometrial invasion, a lym-
phatic invasion and foci of alveolar subtype should
prompt discussion with the patient regarding a more
aggressive surgical treatment [7].
The embryonal botryoide variant is associated with a
much more favorable outcome than the alveolar and the
undifferentiated subtypes, which are associated with a
particularly poor prognosis [4]. Metastatic disease atpresentation and poor response to chemotherapy are
strongly associated with poor prognosis [4]. The ten-
dency of genitourinary RMS to spread to regional lymph
nodes was reported in 26% of cases and the pelvis was
the most common site for primary recurrence (12). The
extent of disease following the primary surgical proce-
dure is the most important prognostic factor in these
patients [8]. Surgery and chemotherapy are the main-
stays of the treatment of cervical RMS, and the progno-
sis of patients treated with multimodal therapy is very
good [4]. In the IRSG, patients with gross residual dis-
ease after initial surgery (Clinical Group III) had a 5
years’ survival rate of approximately 70% compared with
a greater than 90% 5 years’ survival rate for patients
with no residual tumor after surgery (Clinical Group I)
and an approximately 80% 5 years’ survival rate for
patients with microscopic residual tumor following
7surgery (Clinical Group II) [8].
Conclusions
The presence of a cervical polyp, particularly one that has
achieved a size large enough to protrude from the vagina
in a young teenager, is a gynecologic oddity and must
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a RMS. This is extremely important especially as an early
disease stage at diagnosis is a highly favorable prognostic
factor. Surgery and chemotherapy are the mainstays of
treatment of cervical RMS, and the prognosis of patients
treated with multimodal therapy is very good.
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